Skip to content

Living With Long COVID: LONGCOVID-EXPERIENCE

Living With Long COVID: LONGCOVID-EXPERIENCE Qualitative Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06118112
Enrollment
25
Registered
2023-11-07
Start date
2023-09-18
Completion date
2024-12-30
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Experience, Life, Long COVID

Keywords

Post-Acute COVID-19 Syndrome, patient experience, qualitative research

Brief summary

Background: One in ten people infected with COVID-19 presents persistent COVID, which consists of the presence of symptoms three months after the acute manifestations of COVID-19 and their persistence for at least two months, without being explained by an alternative diagnosis. The characteristics and clinical approach to persistent COVID syndrome are fairly well known, but not what the experience of people with persistent COVID is in relation to their daily life, their work life, and their experience with the healthcare received. Objective: to understand the experience of patients with persistent COVID in relation to the disease, the health care received and re-entry into the world of work Methods: Qualitative, descriptive, phenomenological study, based on individual interviews. The study protocol will be registered in Clinicaltrials.gov. People with persistent COVID treated at the Parc Taulí Hospital will be included. Sampling will be by convenience, purposive and snowball and the sample size will be determined by data saturation. Semi-structured individual or group interviews will be conducted and the data will be analyzed following a reflective thematic analysis (Brawn and Clarke). The preliminary report will be triangulated with some participants and with the results obtained from a scoping review carried out by the research team.

Interventions

None listed

Sponsors

Corporacion Parc Tauli
Lead SponsorOTHER
Universitat Autonoma de Barcelona
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* women and men diagnosed with persistent COVID between March '20 to the present according to WHO criteria (persistent symptoms three months after the acute manifestations of COVID-19 and lasting at least two months and cannot be explained by an alternative diagnosis). * treated at the Parc Taulí Hospital * from 18 to 65 years

Exclusion criteria

-people who do not understand or can communicate in Catalan or Spanish.

Design outcomes

Primary

MeasureTime frameDescription
Experience of the diseaseUp to three yearsHow is living with LongCOVID. Assessed through semi-structured interviews.
Experience with healthcare receivedUp to three yearsHow is the experience of patients with the healthcare received for their condition. Assessed through semi-structured interviews.
Experience with return to workUp to three yearsWhat were the barriers and facilitators for returning to work after the disease. Assessed through semi-structures interviews.

Countries

Spain

Contacts

PRINCIPAL_INVESTIGATORAnna Selva, MD, MPH, PhD

Parc Taulí, Hospital Universitari- I3PT

STUDY_DIRECTORJuan Leiva, PhD

Universitat Autònoma Barcelona

PRINCIPAL_INVESTIGATORPilar Peña, MD

Parc Taulí, Hospital Universitari- I3PT

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026